Critical considerations about the generalized use of n-3 polyunsaturated fatty acids in patients with Polycystic Ovary Syndrome.

Ann Palliat Med

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy; The Experts Group on Inositol in Basic and Clinical Research (EGOI), Rome, Italy.

Published: January 2022

Download full-text PDF	Source
http://dx.doi.org/10.21037/apm-21-3430	DOI Listing

Publication Analysis

critical considerations

considerations generalized

generalized n-3

n-3 polyunsaturated

polyunsaturated fatty

fatty acids

acids patients

patients polycystic

polycystic ovary

ovary syndrome

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!